Evidence map›Paper›PMID 22418927›Full record

ArticleMolecules (Basel, Switzerland)2012

Biodegradability and biocompatibility study of poly(chitosan-g-lactic acid) scaffolds.

Zhe Zhang, Huifei Cui

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Polysaccharide-Based Membrane Biocompatibility Study ofMaterials (Basel, Switzerland) · 2022
    Article
  9. Dendritic cell biocompatibility of ether-based urethane films.Journal of applied toxicology : JAT · 2021
    Article
  10. Review
  11. Review
  12. Biodegradable Chitosan-Polymers · 2020
    Article
  13. Aligned microchannel polymer-nanotube composites for peripheral nerve regeneration: Small molecule drug delivery.Journal of controlled release : official journal of the Controlled Release Society · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Zhe ZhangInstitute of Biochemical and Biotechnological Drugs, School of Pharmacy, Shandong University, Jinan 250012, China.
Huifei Cui

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A biodegradable, biocompatible poly(chitosan-g-lactic acid) (PCLA) scaffold was prepared and evaluated in vitro and in vivo. The PCLA scaffold was obtained by grafting lactic acid (LA) onto the amino groups on chitosan (CS) without a catalyst. The PCLA scaffolds were characterized by Fourier Transform infrared spectroscopy (FT-IR) and scanning electron microscopy (SEM). The biodegradabilty was determined by mass loss in vitro, and degradation in vivo as a function of feed ratio of LA/CS. Bone marrow mesenchymal stem cell (BMSC) culture experiments and histological examination were performed to evaluate the PCLA scaffolds' biocompatibility. The results indicated that PCLA was promising for tissue engineering application.

Indexed as

Absorbable ImplantsMaterials TestingAnimalsBiocompatible MaterialsBone Marrow CellsCell ProliferationCells, CulturedCell SurvivalChitosanHydrogen-Ion ConcentrationMesenchymal Stem CellsMiceMuramidasePolyestersPorosityRandom AllocationBiocompatible MaterialsChitosanMuramidasepoly(chitosan-g-lactic acid)Polyesters

Identifiers

PMID22418927
PMCPMC6268052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.